11 February 2021 - Deborah Wilkes
Premium
Worldwide sales at GlaxoSmithKline (GSK) Consumer Healthcare dropped by 7% at constant exchange rates to GBP2.36 billion (USD3.31 billion) in the fourth quarter of 2020 following the recent divestment programme.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.